4D Molecular Therapeutics
FDMT
FDMT
94 hedge funds and large institutions have $522M invested in 4D Molecular Therapeutics in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 24 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
-2
Holders Change %
-2.08%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
40
Reduced
24
Closed
15
Calls
$1.85M
Puts
$2.6M
Net Calls
-$748K
Net Calls Change
-$2.51M
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$35.1M |
| 2 |
NHAS
2
Novo Holdings A/S
Hellerup,
Denmark
|
$12M |
| 3 |
CC
3
Casdin Capital
New York
|
$18.4M |
| 4 |
4
Janus Henderson Group
London,
United Kingdom
|
$32.3M |
| 5 |
5
Morgan Stanley
New York
|
$29.9M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
DC
101
Diametric Capital
Boston,
Massachusetts
| – | -$345K | -15,554 | Closed |
|
102
Allspring Global Investments
Charlotte,
North Carolina
| – | -$283K | -12,758 | Closed |
|
|
PCM
103
Prelude Capital Management
New York
| – | -$281K | -12,631 | Closed |
|
|
FAM
104
Fred Alger Management
New York
| – | -$139K | -6,241 | Closed |
|
|
BAM
105
Belpointe Asset Management
Reno,
Nevada
| – | -$37.1K | -1,671 | Closed |
|
|
HNWAG
106
High Net Worth Advisory Group
Naples,
Florida
| – | -$11.1K | -500 | Closed |
|
107
US Bancorp
Minneapolis,
Minnesota
| – | -$2.51K | -113 | Closed |
|
|
S
108
SignatureFD
Atlanta,
Georgia
| – | -$666 | -30 | Closed |
|
|
MSCM
109
McElhenny Sheffield Capital Management
Dallas,
Texas
| – | -$600 | -27 | Closed |
|